Dr. John Buse
美国北卡罗来纳医学院糖尿病护理中心主任、内分泌科主任和临床研究中心副主任
Dr. John Buse is currently a professor at the University of North Carolina School of Medicine in Chapel Hill， North Carolina where he serves as the Director of the Diabetes Care Center， Chief of the Division of Endocrinology and Executive Associate Dean for Clinical Research.  His research interests focus on developing prevention and treatment strategies for type 1 diabetes， type 2 diabetes and their complications.  He has authored more than 100 publications and is involved in numerous multicenter clinical trials， most prominently ACCORD  study for which he serves as Study Vice-Chair and STOPP-T2D  study.  He serves on the Data Safety Monitoring Board or Steering Committee for NIH and international studies such as NAVIGATOR， ORIGIN， IRIS， FREEDOM and NASH CRN.  Dr. Buse is active in a number of national teaching efforts focusing on graduate medical education as well as CME including programs.
Dr Buse is also President for Medicine and Science at the American Diabetes Association and a board member of the Carolinas Affiliate of the American Association of Clinical Endocrinologists.

Carmine G Fanelli，MD，phD
意大利佩鲁贾大学联合教授
Associate Professor， University of Perugia， Perugia， Italy
cgfanelli@interfree.it
 

John D. Brunzell， M.D.
华盛顿医学院代谢、内分泌及营养系医学教授
Professor Emeritus of Medicine
Division of Metabolism， Endocrinology and Nutrition

OFFICE ADDRESS
University of Washington School of Medicine
1959 NE Pacific Street
UW Mailbox 356426
Seattle， WA 98195-6426

CURRENT RESEARCH INTERESTS
Genetic abnormalities in lipoprotein metabolism. Specific interest in: (1) the pathophysiological and molecular defects in familial combined hyperlipidemia; (2) the role of hepatic lipase gene and activity in determination of dyslipidemia seen in the metabolic syndrome with intraabdominal obesity and insulin resistance in diabetes and at menopause.

brunzell@u.washington.edu
 

Steven M. Willi， MD
美国费城儿童医院糖尿病中心主任
 
CVI Research Description:
I am currently the Medical Director of the Diabetes Center for Children at the Children’s Hospital of Philadelphia. I have research interests in type 1 and type 2 diabetes and their relationship to premature cardiovascular disease.
ITMAT:
Dr. Willi is interested in therapeutics for type 1 and type 2 diabetes and has performed a number of physiologic studies in the etiology and characterization of diabetes in children.
Current studies include three trials on the delay of progression of type 1 diabetes and a multicenter trial to examine the optimal therapeutics for type 2 diabetes in children.
willis@musc.edu     willi@email.chop.edu 

[1]  [2]  下一页